Met-enkephalin
Names | |
---|---|
IUPAC name
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid
| |
Other names
[Met]enkephalin; [Met5]enkephalin; L-Tyrosylglycylglycyl-L-phenylalanyl-L-methionine
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.055.741 |
EC Number |
|
IUPHAR/BPS |
|
KEGG | |
MeSH | Enkephalin,+Methionine |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C27H35N5O7S | |
Molar mass | 573.67 g·mol−1 |
log P | 0.607 |
Acidity (pKa) | 3.234 |
Basicity (pKb) | 10.763 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Met-enkephalin, also known as metenkefalin (
δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.[2]
History
Met-enkephalin was discovered and characterized by John Hughes, Hans Kosterlitz, et al. in 1975 after a search for endogenous ligands of the opioid receptors.[3]
Chemistry
Met-enkephalin is a
]Biochemistry
Distribution
Met-enkephalin is found mainly in the
pelvic viscera.[2]
Biosynthesis
Met-enkephalin is
octapeptide met-enkephalin-arg-gly-leu (186–193),[4] though whether they affect the opioid receptors in a similar manner as met-enkephalin is not entirely clear.[7]
Clearance
Met- and leu-enkephalin are metabolized by a variety of different enzymes, including
dipeptidyl peptidase 3 (DPP3),[8] carboxypeptidase A6 (CPA6),[9] and angiotensin-converting enzyme (ACE).[10] These enzymes are sometimes referred to as enkephalinases
.
Biological activity
Met-enkephalin is a
analgesia and antidepressant
-like effects.
It is also the endogenous
opioid growth factor receptor
(OGFR; formerly known as the ζ-opioid receptor), which plays a role in the regulation of tissue growth and regeneration; hence why met-enkephalin is sometimes called OGF instead.
Pharmacokinetics
Met-enkephalin has low
These properties are considered undesirable in pharmaceuticals as large doses would need to be administered multiple times an hour to maintain a therapeutically relevant effect, making it unlikely that met-enkephalin will ever be used as a medicine.[D-Ala2]-Met-enkephalinamide (DALA), is a synthetic enkephalin analog which is not susceptible to degradation by brain enzymes and at low doses (5 to 10 micrograms) caused profound, long-lasting, morphine-like analgesia when microinjected into a rat’s brain.[12]
See also
References
- PMID 8164525.
- ^ ISBN 978-0-521-62269-1. Retrieved 25 November 2011.
- ^ ISBN 978-0-8493-6894-3. Retrieved 25 November 2011.
- ^ ISBN 978-0-262-19407-5. Retrieved 25 November 2011.
- S2CID 23334563.
- PMID 20040394.
- S2CID 19181608.
- ^ PMID 18855623. Archived from the originalon 2013-04-14.
- PMID 18178555.
- S2CID 23138078.
- ISBN 978-1-4051-3017-2. Retrieved 25 November 2011.
- PMID 968485.